Ironwood Pharmaceuticals Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -10.1% | -6.8% | -9.8% | -1.5% | -9.9% | -6.8% | +4.8% | +15.5% | +0.2% | +9.5% | -34.4% | |
| – | -8.0% | -10.8% | -14.4% | +0.2% | +2.1% | -11.9% | +19.4% | +42.8% | +0.1% | +21.2% | -40.1% | |
| – | -16.3% | +31.9% | -13.2% | -16.4% | +0.4% | +22.5% | -14.4% | +51.2% | +53.5% | +2.3% | -64.1% | |
| – | -16.3% | +31.9% | -13.2% | -16.4% | +0.4% | +22.5% | -14.4% | +51.2% | +53.5% | +2.3% | -64.1% | |
| – | +3.7% | -44.2% | -19.3% | +31.1% | +7.5% | -51.4% | +116.7% | +39.7% | -61.2% | +126.4% | +6.5% | |
| – | -100.0% | – | – | – | – | – | – | – | – | – | – | |
| – | -5.3% | -5.5% | -5.9% | -6.3% | -6.7% | -7.1% | -7.7% | -8.4% | -9.2% | -9.9% | -11.2% | |
| – | -3.8% | -5.9% | -6.8% | -2.3% | -6.9% | +1.4% | -1.5% | +1.4% | -0.2% | -1.1% | -31.4% | |
| – | -1.6% | -8.6% | -82.0% | +8.5% | -21.3% | +23.8% | +383.5% | +4.3% | -0.1% | -2.4% | -86.1% | |
| – | +0.1% | +0.1% | -98.4% | +0.5% | +0.5% | +0.5% | +6,221.8% | +0.1% | +0.1% | +0.1% | -98.4% | |
| – | +66.7% | -20.5% | -48.1% | +0.3% | -34.3% | +174.0% | -76.2% | +16.1% | +79.7% | +11.7% | -71.9% | |
| – | -4.7% | -5.0% | +31.7% | -4.0% | -2.5% | +0.0% | -34.1% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -16.5% | +1.1% | +0.8% | +0.8% | +0.1% | +0.3% | +0.5% | +9.9% | +0.0% | -6.2% | -0.7% |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.